Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
CD19/70 Bi-specific CAR-T Cell TherapyB Cell MalignanciesNot yet recruitingPhase 1 / Phase 22026-08-26NCT05436496

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Shenzhen Geno-Immune Medical Institute43

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Shenzhen Geno-Immune Medical InstituteShenzhenChina39